FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896548682> ?p ?o ?g. }

• W2896548682 endingPage "126" @default.
• W2896548682 startingPage "112" @default.
• W2896548682 abstract "The critical T790M mutation in EGFR, which mediates resistance to first- and second-generation EGFR tyrosine kinase inhibitors (TKI; gefitinib, erlotinib, and afatinib), has facilitated the development of third-generation mutation-selective EGFR TKIs (rociletinib and osimertinib). We previously reported heterogeneous afatinib-resistant mechanisms, including emergence of T790M-EGFR, and responses to third-generation EGFR TKIs. Here, we used afatinib-resistant lung adenocarcinoma cells [AfaR (formerly AFR3) cells], carrying exon 19 deletion/T790M in EGFR To identify the novel resistance mechanisms in post-afatinib treatment, RocR1/RocR2 and OsiR1/OsiR2 cells were established using increasing concentrations of rociletinib and osimertinib, respectively. Attenuation of exon 19 deletion and T790M was confirmed in both rociletinib-resistant cells; in addition, EGFR and KRAS amplification was observed in RocR1 and RocR2, respectively. Significant KRAS amplification was observed in the osimertinib-resistant cell lines, indicating a linear and reversible increase with increased osimertinib concentrations in OsiR1 and OsiR2 cells. OsiR1 cells maintained osimertinib resistance with KRAS amplification after osimertinib withdrawal for 2 months. OsiR2 cells exhibited KRAS attenuation, and osimertinib sensitivity was entirely recovered. Phospho-EGFR (Y1068) and growth factor receptor-bound protein 2 (GRB2)/son of sevenless homolog 1 (SOS1) complex was found to mediate osimertinib resistance in OsiR1 cells with sustained KRAS activation. After 2 months of osimertinib withdrawal, this complex was dissociated, and the EGFR signal, but not the GRB2/SOS1 signal, was activated. Concomitant inhibition of MAPK kinase and EGFR could overcome osimertinib resistance. Thus, we identified a heterogeneous acquired resistance mechanism for third-generation EGFR TKIs, providing insights into the development of novel treatment strategies." @default.
• W2896548682 created "2018-10-26" @default.
• W2896548682 creator A5005363653 @default.
• W2896548682 creator A5009618044 @default.
• W2896548682 creator A5012322249 @default.
• W2896548682 creator A5019102133 @default.
• W2896548682 creator A5031425215 @default.
• W2896548682 creator A5058813774 @default.
• W2896548682 creator A5077367961 @default.
• W2896548682 creator A5078733862 @default.
• W2896548682 creator A5081950928 @default.
• W2896548682 creator A5088472762 @default.
• W2896548682 creator A5088996837 @default.
• W2896548682 date "2019-01-01" @default.
• W2896548682 modified "2023-10-07" @default.
• W2896548682 title "<i>KRAS</i> and <i>EGFR</i> Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in <i>EGFR</i>" @default.
• W2896548682 cites W1546552389 @default.
• W2896548682 cites W1904060183 @default.
• W2896548682 cites W1980497534 @default.
• W2896548682 cites W1987681742 @default.
• W2896548682 cites W1987709860 @default.
• W2896548682 cites W1990938833 @default.
• W2896548682 cites W1994499102 @default.
• W2896548682 cites W2003984225 @default.
• W2896548682 cites W2019439252 @default.
• W2896548682 cites W2022840517 @default.
• W2896548682 cites W2030733555 @default.
• W2896548682 cites W2050211354 @default.
• W2896548682 cites W2057477702 @default.
• W2896548682 cites W2065293650 @default.
• W2896548682 cites W2071018921 @default.
• W2896548682 cites W2076178766 @default.
• W2896548682 cites W2081801534 @default.
• W2896548682 cites W2088540000 @default.
• W2896548682 cites W2095618958 @default.
• W2896548682 cites W2096198395 @default.
• W2896548682 cites W2100738068 @default.
• W2896548682 cites W2117784514 @default.
• W2896548682 cites W2126177831 @default.
• W2896548682 cites W2132157071 @default.
• W2896548682 cites W2140932756 @default.
• W2896548682 cites W2143611932 @default.
• W2896548682 cites W2146418087 @default.
• W2896548682 cites W2150840254 @default.
• W2896548682 cites W2157016650 @default.
• W2896548682 cites W2160982674 @default.
• W2896548682 cites W2166084034 @default.
• W2896548682 cites W2171416485 @default.
• W2896548682 cites W2270997383 @default.
• W2896548682 cites W2342364781 @default.
• W2896548682 cites W2413097448 @default.
• W2896548682 cites W2416111151 @default.
• W2896548682 cites W2508624127 @default.
• W2896548682 cites W2508651937 @default.
• W2896548682 cites W2560717039 @default.
• W2896548682 cites W2588764077 @default.
• W2896548682 cites W2597070303 @default.
• W2896548682 cites W2605449696 @default.
• W2896548682 cites W2615043197 @default.
• W2896548682 cites W2736887233 @default.
• W2896548682 cites W2747965175 @default.
• W2896548682 cites W2766908732 @default.
• W2896548682 cites W2769241338 @default.
• W2896548682 cites W2769659311 @default.
• W2896548682 doi "https://doi.org/10.1158/1535-7163.mct-18-0591" @default.
• W2896548682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30322949" @default.
• W2896548682 hasPublicationYear "2019" @default.
• W2896548682 type Work @default.
• W2896548682 sameAs 2896548682 @default.
• W2896548682 citedByCount "36" @default.
• W2896548682 countsByYear W28965486822019 @default.
• W2896548682 countsByYear W28965486822020 @default.
• W2896548682 countsByYear W28965486822021 @default.
• W2896548682 countsByYear W28965486822022 @default.
• W2896548682 countsByYear W28965486822023 @default.
• W2896548682 crossrefType "journal-article" @default.
• W2896548682 hasAuthorship W2896548682A5005363653 @default.
• W2896548682 hasAuthorship W2896548682A5009618044 @default.
• W2896548682 hasAuthorship W2896548682A5012322249 @default.
• W2896548682 hasAuthorship W2896548682A5019102133 @default.
• W2896548682 hasAuthorship W2896548682A5031425215 @default.
• W2896548682 hasAuthorship W2896548682A5058813774 @default.
• W2896548682 hasAuthorship W2896548682A5077367961 @default.
• W2896548682 hasAuthorship W2896548682A5078733862 @default.
• W2896548682 hasAuthorship W2896548682A5081950928 @default.
• W2896548682 hasAuthorship W2896548682A5088472762 @default.
• W2896548682 hasAuthorship W2896548682A5088996837 @default.
• W2896548682 hasConcept C104317684 @default.
• W2896548682 hasConcept C121608353 @default.
• W2896548682 hasConcept C126322002 @default.
• W2896548682 hasConcept C2776256026 @default.
• W2896548682 hasConcept C2777626846 @default.
• W2896548682 hasConcept C2777930144 @default.
• W2896548682 hasConcept C2778087573 @default.
• W2896548682 hasConcept C2779438470 @default.
• W2896548682 hasConcept C2780580887 @default.
• W2896548682 hasConcept C2780586478 @default.
• W2896548682 hasConcept C2781187634 @default.

• next